These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35919076)

  • 1. Silymarin Administration Attenuates Cirrhotic-induced Cardiac Abnormality in the Rats: A Possible Role of β
    Bayat G; Mazloom R; Hashemi SA; Pourkhalili K; Fallah P; Shams A; Esmaeili P; Khalili A
    Iran J Med Sci; 2022 Jul; 47(4):367-378. PubMed ID: 35919076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
    Younis N; Shaheen MA; Abdallah MH
    Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effects of Spermidine Against Cirrhotic Cardiomyopathy in Bile Duct-Ligated Rats.
    Sheibani M; Nezamoleslami S; Mousavi SE; Faghir-Ghanesefat H; Yousefi-Manesh H; Rezayat SM; Dehpour A
    J Cardiovasc Pharmacol; 2020 Sep; 76(3):286-295. PubMed ID: 32902943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats.
    Yoon KT; Liu H; Zhang J; Han S; Lee SS
    Clin Mol Hepatol; 2022 Apr; 28(2):232-241. PubMed ID: 34986297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated rats.
    Ahmed AF; Mahmoud MF; Ouf MA; El-Fathaah EA
    Ann Hepatol; 2011; 10(2):207-15. PubMed ID: 21502683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage.
    Abdel-Moneim AM; Al-Kahtani MA; El-Kersh MA; Al-Omair MA
    PLoS One; 2015; 10(12):e0144509. PubMed ID: 26659465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silymarin inhibits the progression of fibrosis in the early stages of liver injury in CCl₄-treated rats.
    Clichici S; Olteanu D; Nagy AL; Oros A; Filip A; Mircea PA
    J Med Food; 2015 Mar; 18(3):290-8. PubMed ID: 25133972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary cirrhosis-induced cardiac abnormality in rats: Interaction between Farnesoid-X-activated receptors and the cardiac uncoupling proteins 2 and 3.
    Bayat G; Hashemi SA; Karim H; Fallah P; Hedayatyanfard K; Bayat M; Khalili A
    Iran J Basic Med Sci; 2022 Jan; 25(1):126-133. PubMed ID: 35656450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lactulose and silymarin on liver enzymes in cirrhotic rats.
    Ghobadi Pour M; Mirazi N; Alaei H; Moradkhani S; Rajaei Z; Monsef Esfahani A
    Can J Physiol Pharmacol; 2017 May; 95(5):522-529. PubMed ID: 28281782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHSST cyclodextrin complex prevents the fibrosis effect on CCl₄-induced cirrhotic cardiomyopathy in rats through TGF-β pathway inhibition effects.
    Yang CH; Ting WJ; Day CH; Ju DT; Yeh YL; Chung LC; Tsai FJ; Tsai CH; Tsai Y; Huang CY
    Int J Mol Sci; 2014 May; 15(5):8037-48. PubMed ID: 24815066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
    Liu H; Ma Z; Lee SS
    Gastroenterology; 2000 May; 118(5):937-44. PubMed ID: 10784593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis.
    Lee GJ; Yan L; Vatner DE; Vatner SF
    Basic Res Cardiol; 2015 Mar; 110(2):7. PubMed ID: 25600225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into hepatic and renal FXR/DDAH-1/eNOS pathway and its role in the potential benefit of rosuvastatin and silymarin in hepatic nephropathy.
    Magdy YM; El-Kharashi OA; El-Waseef DAA; Nabih ES; Abd El Samad AA
    Exp Mol Pathol; 2018 Dec; 105(3):293-310. PubMed ID: 30308196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of lamivudine and silymarin on liver fibrosis-relevant factors in HBV transgenic mice with alcohol drinking].
    Huang J; Liu S; Li Z; Cao L; Ouyang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):257-263. PubMed ID: 28364097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats].
    Zhao XY; Wang BE; Wang TL; Li XM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2563-6. PubMed ID: 17198567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Chronic Losartan Treatment Effect on Cardiac Chronotropic Dysfunction in Biliary Cirrhotic Rats.
    Jazaeri F; Afsharmoghaddam R; Abdollahi A; Ghamami G; Dehpour AR
    Acta Med Iran; 2018 Jan; 56(1):4-13. PubMed ID: 29436789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
    Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
    BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats.
    Sokar SS; El-Sayad ME; Ghoneim ME; Shebl AM
    Biomed Pharmacother; 2017 May; 89():98-107. PubMed ID: 28222401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effect of silymarin against linezolid-induced hepatotoxicity in methicillin-resistant Staphylococcus aureus (MRSA) infected Wistar rats.
    Vivekanandan L; Sheik H; Singaravel S; Thangavel S
    Biomed Pharmacother; 2018 Dec; 108():1303-1312. PubMed ID: 30372832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy.
    Ma Z; Lee SS; Meddings JB
    J Hepatol; 1997 Apr; 26(4):904-12. PubMed ID: 9126806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.